The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
£800-900m*
Why would anyone pay £800-90 for a company that is currently worth £50m and bleeding money daily?
Hi Neil, from what I can see there is a brand new unit 1b up for lease.
https://watchmoorpoint.co.uk/
If you look at what happened at Amryt Pharma , basically every single investor holding their shares profited when Amryt Pharma were taken over and the share was priced at their highest ever achieved in history . Lets hope his nightmare with Novacyt is over soon and we get £12 / share when eurofins take over or one of the big pharma boys .
https://www.google.co.uk/search?q=amryt+share+price&ei=5HDZY5zSBsOPhbIP-8WLyAo&oq=amryt&gs_lcp=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-whYixtgni5oAXAAeACAAXWIAdMDkgEDMy4ymAEAoAEBsAEKwAEB2gEECAEYCg&sclient=gws-wiz-serp
Prior to the pandemic Microgens turnover was approx £2.6m.
I'd hazard a guess at Hungary. But cheaper than uk
Perhaps they have retained 1B and the unit has been divided, was it not simply 1 previously?
Where have Eurofins moved the Camberley production to, because if I am correct the property on Watchpoint road is back on the market for lease as of 23/01/23
https://property link.estatesgazette.com/property-details/6879781-unit-1a-watchmoor-point-watchmoor-road
Maybe. But that would be highly unprofessional. Especially as the sell happend at end of june !
But i have no clue either, it's not making much sensé atm
Maybe, however we retained the Pathflow range of products, yet still listed upon the Microgen website.
I guess that they have purchased the domain with the name, however as yet they've not replaced the webpage.
Tks Bullraider
As for the microgen but alas I think we are being ran by a bunch of cowboys, I'll still be here come the Agm though.
Neilrich, eurofins also redirect to that website : https://www.eurofins.com/contact-us/worldwide-interactive-map/united-kingdom/eurofins-microgen/
Novacyt Microgen Website remains and we can view their existing product offering:
https://microgenbioproducts.com/
WBAFC, Not necessarily, some of that revenue was inter-company, for instance Microgen manufactured tests for Primerdesign. Also, there's a cost associated with closing a business and I'd imagine Novacyt removed the parts of the business which they wished to amalgamate into Novacyt. For all we know Eurofins purchased the name and what was left after Novacyt had taken the parts out that it wished to retain. Interesting that they acquired our business address, I suspect that they are renting the premises, but don't know for sure.
Depends how many assets of the co theyve bought
https://www.linkedin.com/posts/goldstandarddiagnostics_pathogens-foodsafety-foodandbeverageindustry-activity-7026180159531560961-CRf2?utm_source=share&utm_medium=member_ios
Nice little video aswell. Unbelievable
So , if microgen generated £4M / year , then surely Novacyt would have sold this far more than £4M
Better sell some assets rather than close the co and get nothing.
For how much ? Less than needed to have an rns apparently, so not much i guess.
Full takeover ? I would Say no.
Microgen generated revenue of >£4m in 2021, therefore there was value there.
Again , I ask what benefit to Novacyt gain from selling off microgen portfolio to eurofin ? And how much for ? Is this the start of a full take over by eurofins or merger with eurofins
Ms team leader on these online meetings will notify with a code to all invitees. To enable your participation you must have this. I think all shareholders should be represented, nothing to stop you applying for an invite
Now that there is a major investigation into the COVID fiddles that broke the health bank, just perhaps good publicity as the company has done nothing wrong except perhaps having once employed a dodgy dentist.
"not material enough" said IR.
Shareholders have gone way past the point where an RNS was necessary on this subject.
Money has changed hands to purchase rights for goodness sake.
I wrote to SP Angel, - the NOMAD, - to complain about the above situation on two occasions,
urging them to investigate and advise.
I haven't heard a word, they're probably still laughing.